Cover Image

Mean Platelet Volume as a surrogate marker of disease activity in Systemic Lupus Erythematosus

KAVITHA M .

Abstract


Mean Platelet Volume(MPV) is being increasingly studied in chronic inflammatory disease as a marker of          inflammation. Our study aimed at studying it as a possible surrogate marker of disease activity in systemic lupus             erythematosus(SLE). The study was conducted for a period of 6 months from January 2014 to September 2014. It            included both childhood and adult lupus and SLEDAI 2k was taken as a measure of disease activity. Mean platelet volume was assessed in 200 healthy controls, a cut off value of 9.48fL was taken with a sensitivity of 86 and specificity of 90. 150 SLE patients in remission were studied along with 50 SLE patients with disease flare. Patients with remission had MPV and ESR comparable to that of healthy controls whereas in active disease both MPV and ESR were             significantly elevated to that of healthy controls. Serum           complements C3, C4 were significantly lower in patients with active disease. MPV had a positive correlation with ESR and SLEDAI and negative correlation with complements. The study implied that MPV can be used as a surrogate marker of disease activity in SLE in resource limited settings


Full Text:

PDF

References


Sham S, Madeshwaran M, Tamilselvam TN, Sankaralingam R. ESR, uric acid and its correlation with disease activity in SLE – Is it a myth or reality!!! Ind J Rheu 2015;10:112-3.DOI:

http://dx.doi.org/10.1016/j.injr.2015.02.007

.Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47-58.

Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke. 2004;35:1688 -91.

Yilmaz MB, Cihan G, Guray Y, Guray U, Kisacik HL, Sasmaz H, Korkmaz S. Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis. 2008;26:49-54.

Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009; 63: 1509–1515.

Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13: 301–306.

Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Rheumatol Int. 2010;30:1125-1129.

Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint, bone, spine: revue du rhumatisme 2008;75:291-4.

Oncel MY, Ozdemir R, Yurttutan S, Canpolat FE, Erdeve O, Oguz SS et al. Mean platelet volume in neonatal sepsis. J Clin Lab Anal 2012;26:493–6.

Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner OF. Mean Platelet Volume May Represent a Predictive Parameter for Overall Vascular event. Arterioscler Thromb Vasc Biol.2011;31:1215-8.

Nagahama M, Nomura S, Ozaki Y, Yoshimura C, Kagawa H, Fukuhara S. Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity 2001;33:85-94.

Safak S, Uslu AU , Serdal K, Turker T, Soner S, Lutfi A. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis. African Health Sciences 2014; 14(4):919-24.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University